CBL and COVID-19: We showed that serum CBL levels >101 ng/mL, with a sensitivity of 60% (CI: 40.74 to 76.60%) and specificity of 72% (CI: 52.42 to 85.72%), differentiate COVID-19 deceased from recovered patients.